Renalytix Plc (RENX.L)

GBp 9.5

(0.0%)

Annual Income Statements

(In EUR)
Breakdown 2023 2023 2022 2021 2020 2019
Revenue 59.6 Billion 3.4 Million 2.97 Million 1.49 Million 58.3 Billion -
Cost of Revenue 34.42 Billion 2.7 Million 2.05 Million 804 Thousand 32.64 Billion -
Gross Profit 25.17 Billion 701 Thousand 918 Thousand 687 Thousand 25.66 Billion -
Operating Expenses 15.2 Billion 43.05 Million 58.29 Million 33.29 Million 8.84 Million 6.53 Million
Selling, General and Administrative Expenses 15.13 Billion 43.05 Million 12.95 Million 8.37 Million 5.11 Million 6.53 Million
Research and Development Expenses 949 Million 14.29 Million 14.64 Million 10.04 Million 4.06 Million 34.82 Million
Other Expenses - 656 Thousand 131 Thousand 726 Thousand - -
Cost and Expenses 49.63 Billion 45.75 Million 60.34 Million 34.1 Million 8.84 Million 6.53 Million
Operating Income 10.06 Billion -42.35 Million -57.37 Million -32.61 Million -9.17 Million -6.53 Million
Interest Expense - 2000.00 2000.00 3000.00 604.59 Million 20 Thousand
Income Tax Expense 2.19 Billion 2000.00 7.1 Million -4.77 Million 2.53 Billion -959 Thousand
Earnings before Tax 9.33 Billion -46.22 Million -49.62 Million -35.78 Million -8.76 Million -6.51 Million
Net Income 6.48 Billion -46.22 Million -56.73 Million -31.01 Million -8.76 Million -5.55 Million
Earnings Per Share Basic 2.56 -0.56 -0.78 -0.43 -0.15 -0.15
Earnings Per Share Diluted 2.56 -0.56 -0.77 -0.43 -0.15 -0.15
Weighted Average Shares Outstanding 94.27 Million 82.21 Million 72.86 Million 71.48 Million 57.9 Million 37.33 Million
Weighted Average Shares Outstanding (Diluted) 97.26 Million 82.21 Million 73.83 Million 71.48 Million 59.07 Million 37.33 Million
Gross Margin 0.42 0.21 0.31 0.46 0.44 -
EBIT Margin 0.19 -10.43 -15.19 -26.43 -0.00 -
Profit Margin 0.11 -13.58 -19.10 -20.80 -0.00 -
EBITDA 11.05 Billion -35.49 Million -45.11 Million -39.41 Million -9.11 Million -5.37 Million
Earnings Before Tax Margin 0.17 -12.45 -19.32 -21.87 -0.00 -

Income Statement Charts